{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,18]],"date-time":"2026-07-18T11:20:59Z","timestamp":1784373659261,"version":"3.55.0"},"reference-count":26,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2024,4,1]],"date-time":"2024-04-01T00:00:00Z","timestamp":1711929600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,4,1]],"date-time":"2024-04-01T00:00:00Z","timestamp":1711929600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,1,4]],"date-time":"2024-01-04T00:00:00Z","timestamp":1704326400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.es","clinicalkey.com.au","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Urologic Oncology: Seminars and Original Investigations"],"published-print":{"date-parts":[[2024,4]]},"DOI":"10.1016\/j.urolonc.2023.12.014","type":"journal-article","created":{"date-parts":[[2024,1,17]],"date-time":"2024-01-17T12:41:25Z","timestamp":1705495285000},"page":"117.e11-117.e16","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":6,"title":["Longer time to radical cystectomy in patients treated with neoadjuvant chemotherapy is associated with worse oncological outcomes"],"prefix":"10.1016","volume":"42","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-0425-6479","authenticated-orcid":false,"given":"Siberyn T.","family":"Nuijens","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Frits H.M.","family":"van Osch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lisa M.C.","family":"van Hoogstraten","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J. Alfred","family":"Witjes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katja K.H.","family":"Aben","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tom J.N.","family":"Hermans","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.urolonc.2023.12.014_bib0001","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1016\/j.eururo.2020.03.055","article-title":"European association of urology guidelines on muscle-invasive and metastatic bladder cancer: summary of the 2020 guidelines","volume":"79","author":"Witjes","year":"2021","journal-title":"Eur Urol"},{"issue":"3","key":"10.1016\/j.urolonc.2023.12.014_bib0002","doi-asserted-by":"crossref","first-page":"552","DOI":"10.1016\/j.juro.2017.04.086","article-title":"Treatment of non-metastatic muscle-invasive bladder cancer: AUA\/ASCO\/ASTRO\/SUO guideline","volume":"198","author":"Chang","year":"2017","journal-title":"J Urol"},{"issue":"6","key":"10.1016\/j.urolonc.2023.12.014_bib0003","doi-asserted-by":"crossref","first-page":"708","DOI":"10.1634\/theoncologist.2015-0440","article-title":"Neoadjuvant chemotherapy for muscle-invasive bladder cancer: a systematic review and two-step meta-analysis","volume":"21","author":"Yin","year":"2016","journal-title":"Oncologist"},{"issue":"9","key":"10.1016\/j.urolonc.2023.12.014_bib0004","doi-asserted-by":"crossref","first-page":"859","DOI":"10.1056\/NEJMoa022148","article-title":"Neoadjuvant chemotherapy plus cystectomy compared with cystectomy alone for locally advanced bladder cancer","volume":"349","author":"Grossman","year":"2003","journal-title":"N Engl J Med"},{"issue":"3","key":"10.1016\/j.urolonc.2023.12.014_bib0005","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1016\/j.eururo.2014.01.014","article-title":"The effect of neoadjuvant chemotherapy on perioperative outcomes in patients who have bladder cancer treated with radical cystectomy: a population-based study","volume":"66","author":"Gandaglia","year":"2014","journal-title":"Eur Urol"},{"issue":"2","key":"10.1016\/j.urolonc.2023.12.014_bib0006","first-page":"24","article-title":"Trends and disparities in the use of neoadjuvant chemotherapy for muscle-invasive urothelial carcinoma","volume":"13","author":"Duplisea","year":"2019","journal-title":"Can Urol Assoc J"},{"key":"10.1016\/j.urolonc.2023.12.014_bib0007","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1016\/j.ejca.2015.11.006","article-title":"Perioperative treatment and radical cystectomy for bladder cancer: a population based trend analysis of 10,338 patients in the Netherlands","volume":"54","author":"Hermans","year":"2016","journal-title":"Eur J Cancer"},{"issue":"7","key":"10.1016\/j.urolonc.2023.12.014_bib0008","doi-asserted-by":"crossref","first-page":"1837","DOI":"10.1007\/s00345-023-04443-7","article-title":"Low adherence to recommended use of neoadjuvant chemotherapy for muscle-invasive bladder cancer","volume":"41","author":"Van Hoogstraten","year":"2023","journal-title":"World J Urol"},{"key":"10.1016\/j.urolonc.2023.12.014_bib0009","doi-asserted-by":"crossref","DOI":"10.1155\/2014\/746298","article-title":"Neoadjuvant chemotherapy use in bladder cancer: a survey of current practice and opinions","volume":"2014","author":"Cowan","year":"2014","journal-title":"Adv Urol"},{"issue":"2","key":"10.1016\/j.urolonc.2023.12.014_bib0010","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1016\/j.euo.2019.09.008","article-title":"A systematic review and meta-analysis of delay in radical cystectomy and the effect on survival in bladder cancer patients","volume":"3","author":"Russell","year":"2020","journal-title":"Eur Urol Oncol"},{"issue":"1","key":"10.1016\/j.urolonc.2023.12.014_bib0011","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1002\/cncr.26240","article-title":"Efficient delivery of radical cystectomy after neoadjuvant chemotherapy for muscle-invasive bladder cancer: a multidisciplinary approach","volume":"118","author":"Alva","year":"2012","journal-title":"Cancer"},{"issue":"4","key":"10.1016\/j.urolonc.2023.12.014_bib0012","doi-asserted-by":"crossref","first-page":"166.e1","DOI":"10.1016\/j.urolonc.2015.11.006","article-title":"The effect of the time interval between diagnosis of muscle-invasive bladder cancer and radical cystectomy on staging and survival: Netherlands Cancer Registry analysis","volume":"34","author":"Bruins","year":"2016","journal-title":"Urol Oncol"},{"issue":"4","key":"10.1016\/j.urolonc.2023.12.014_bib0013","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1016\/j.euo.2018.09.004","article-title":"Delaying radical cystectomy after neoadjuvant chemotherapy for muscle-invasive bladder cancer is associated with adverse survival outcomes","volume":"2","author":"Boeri","year":"2019","journal-title":"Eur Urol Oncol"},{"issue":"12","key":"10.1016\/j.urolonc.2023.12.014_bib0014","doi-asserted-by":"crossref","first-page":"2011","DOI":"10.1002\/cncr.32048","article-title":"Delays in radical cystectomy for muscle-invasive bladder cancer","volume":"125","author":"Chu","year":"2019","journal-title":"Cancer"},{"issue":"2","key":"10.1016\/j.urolonc.2023.12.014_bib0015","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1016\/j.urolonc.2018.11.011","article-title":"A delay \u22658 weeks to neoadjuvant chemotherapy before radical cystectomy increases the risk of upstaging","volume":"37","author":"Audenet","year":"2019","journal-title":"Urol Oncol"},{"issue":"1","key":"10.1016\/j.urolonc.2023.12.014_bib0016","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1186\/s12885-020-06954-7","article-title":"Insight into bladder cancer care: study protocol of a large nationwide prospective cohort study (BlaZIB)","volume":"20","author":"Ripping","year":"2020","journal-title":"BMC Cancer"},{"issue":"1","key":"10.1016\/j.urolonc.2023.12.014_bib0017","first-page":"19","article-title":"Pathology databanking and biobanking in The Netherlands, a central role for PALGA, the nationwide histopathology and cytopathology data network and archive","volume":"29","author":"Casparie","year":"2007","journal-title":"Cell Oncol"},{"key":"10.1016\/j.urolonc.2023.12.014_bib0018","unstructured":"Fritz, April, Percy, Constance, Jack, Andrew, Shanmugaratnam, Kanagaratnam, Sobin, Leslie H. et al. International classification of diseases for oncology, 3rd ed. World Health Organization; 2000."},{"key":"10.1016\/j.urolonc.2023.12.014_bib0019","series-title":"TNM classification of malignant tumours","author":"Brierley","year":"2017"},{"issue":"4 Pt 1","key":"10.1016\/j.urolonc.2023.12.014_bib0020","doi-asserted-by":"crossref","first-page":"880","DOI":"10.1016\/j.juro.2015.11.024","article-title":"A retrospective analysis of the effect on survival of time from diagnosis to neoadjuvant chemotherapy to cystectomy for muscle invasive bladder cancer","volume":"195","author":"Park","year":"2016","journal-title":"J Urol"},{"issue":"1","key":"10.1016\/j.urolonc.2023.12.014_bib0021","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1111\/bju.14211","article-title":"Determining the optimal time for radical cystectomy after neoadjuvant chemotherapy","volume":"122","author":"Mmeje","year":"2018","journal-title":"BJU Int"},{"issue":"11","key":"10.1016\/j.urolonc.2023.12.014_bib0022","doi-asserted-by":"crossref","first-page":"2409","DOI":"10.1007\/s00345-019-02689-8","article-title":"Clinical predictors and survival outcome of patients receiving suboptimal neoadjuvant chemotherapy and radical cystectomy for muscle-invasive bladder cancer: a single-center experience","volume":"37","author":"Boeri","year":"2019","journal-title":"World J Urol"},{"issue":"9","key":"10.1016\/j.urolonc.2023.12.014_bib0023","doi-asserted-by":"crossref","first-page":"386.e1","DOI":"10.1016\/j.urolonc.2015.05.028","article-title":"Neoadjuvant chemotherapy administration and time to cystectomy for muscle-invasive bladder cancer: an evaluation of transitions between academic and community settings","volume":"33","author":"Rose","year":"2015","journal-title":"Urol Oncol"},{"issue":"1","key":"10.1016\/j.urolonc.2023.12.014_bib0024","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1016\/S0022-5347(05)64047-5","article-title":"An interval longer than 12 weeks between the diagnosis of muscle invasion and cystectomy is associated with worse outcome in bladder carcinoma","volume":"169","author":"S\u00c1Nchez-Ortiz","year":"2003","journal-title":"J Urol"},{"issue":"4","key":"10.1016\/j.urolonc.2023.12.014_bib0025","doi-asserted-by":"crossref","first-page":"1262","DOI":"10.1016\/S0022-5347(05)00644-0","article-title":"Cystectomy delay more than 3 months from initial bladder cancer diagnosis results in decreased disease specific and overall survival","volume":"175","author":"Lee","year":"2006","journal-title":"J Urol"},{"issue":"4 Pt 1","key":"10.1016\/j.urolonc.2023.12.014_bib0026","doi-asserted-by":"crossref","first-page":"1085","DOI":"10.1097\/01.ju.0000086828.26001.ca","article-title":"Delaying radical cystectomy for muscle invasive bladder cancer results in worse pathological stage","volume":"170","author":"Chang","year":"2003","journal-title":"J Urol"}],"container-title":["Urologic Oncology: Seminars and Original Investigations"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1078143923005112?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1078143923005112?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,11,6]],"date-time":"2024-11-06T03:46:38Z","timestamp":1730864798000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1078143923005112"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,4]]},"references-count":26,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2024,4]]}},"alternative-id":["S1078143923005112"],"URL":"https:\/\/doi.org\/10.1016\/j.urolonc.2023.12.014","relation":{},"ISSN":["1078-1439"],"issn-type":[{"value":"1078-1439","type":"print"}],"subject":[],"published":{"date-parts":[[2024,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Longer time to radical cystectomy in patients treated with neoadjuvant chemotherapy is associated with worse oncological outcomes","name":"articletitle","label":"Article Title"},{"value":"Urologic Oncology: Seminars and Original Investigations","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.urolonc.2023.12.014","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Author(s). Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}